These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17012123)

  • 1. The influence of formulation on the dissolution profile of diclofenac sodium tablets.
    De Castro WV; Pires MA; Oliveira MA; Vianna-Soares CD; Nunan EA; Pianetti GA; Moreira-Campos LM; De Castro WV; Mertens-Talcott SU; Derendorf H
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1103-9. PubMed ID: 17012123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro studies of enteric coated diclofenac sodium-carboxymethylcellulose microspheres.
    Arica B; Arica MY; Kaş HS; Hincal AA; Hasirci V
    J Microencapsul; 1996; 13(6):689-99. PubMed ID: 8933354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of thermal treatment on the release behavior of diclofenac sodium from acrylic matrices.
    Azarmi S; Farid D; Azodi-Deylami S; Ghaffari F; Nokhodchi A
    Pharm Dev Technol; 2005; 10(2):233-9. PubMed ID: 15926672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
    Speer I; Lenhart V; Preis M; Breitkreutz J
    Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
    Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
    Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approach of aceclofenac fast dissolving tablet.
    Dave V; Yadav S; Sharma S; Vishwakarma P; Ali N
    Pak J Pharm Sci; 2015 Jan; 28(1):37-41. PubMed ID: 25553683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
    Alsarra IA
    Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction.
    Adeyeye MC; Mwangi E; Katondo B; Jain A; Ichikawa H; Fukumori Y
    J Microencapsul; 2005 Jun; 22(4):333-42. PubMed ID: 16214782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU; Shah KU; Rehman A; Khan GM
    Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
    Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation.
    Bindra DS; Stein D; Pandey P; Barbour N
    Pharm Dev Technol; 2014 May; 19(3):285-9. PubMed ID: 23528069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
    Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
    Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
    Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geometry of modified release formulations during dissolution--influence on performance of dosage forms with diclofenac sodium.
    Dorożyński P; Kulinowski P; Jamróz W; Juszczyk E
    Int J Pharm; 2014 Dec; 477(1-2):57-63. PubMed ID: 25311175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.